These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25306774)

  • 21. Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
    Peacock GF; Sauvageot J; Hill A; Killian A
    Int J Pharm Compd; 2016; 20(1):81-5. PubMed ID: 27125058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
    Gorman G; Sokom S; Coward L; Arnold JJ
    Int J Pharm Compd; 2017; 21(2):164-170. PubMed ID: 28346213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of lecithin organogel for topical delivery of fluconazole.
    Jadhav KR; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2009 Apr; 6(2):174-83. PubMed ID: 19450224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester.
    McKinney RD; Dunbar JR
    Int J Pharm Compd; 2021; 25(3):241-245. PubMed ID: 34125715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluronic lecithin organogel of 5-aminosalicylic acid for wound healing.
    Sanapalli BKR; Kannan E; Balasubramanian S; Natarajan J; Baruah UK; Karri VVSR
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1650-1658. PubMed ID: 29848103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of methimazole in poloxamer lecithin organogel to determine beyond-use date.
    Pignato A; Pankaskie M; Birnie C
    Int J Pharm Compd; 2010; 14(6):522-5. PubMed ID: 23965656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Transdermal Drug Permeation as Modulated by Lipoderm and Pluronic Lecithin Organogel.
    Zhang Q; Song Y; Page SW; Garg S
    J Pharm Sci; 2018 Feb; 107(2):587-594. PubMed ID: 28935590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and Evaluation of Pluronic Lecithin Organogels in Cosmetics.
    Jun Yang S; Yoon KS
    J Cosmet Sci; 2021; 72(3):325-346. PubMed ID: 35361319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation, rheological study, and characterization of an organogel as a system for transdermal release of active principles.
    Ruiz MA; Clares B; Morales ME; Gallardo V
    Pharm Dev Technol; 2007; 12(6):637-44. PubMed ID: 18161637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical delivery of aceclofenac from lecithin organogels: preformulation study.
    Shaikh IM; Jadhav KR; Gide PS; Kadam VJ; Pisal SS
    Curr Drug Deliv; 2006 Oct; 3(4):417-27. PubMed ID: 17076644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-Assembling Organogels Based on Pluronic and Lecithin for Sustained Release of Etodolac: In Vitro and In Vivo Correlation.
    Mohammed AM; Faisal W; Saleh KI; Osman SK
    Curr Drug Deliv; 2017; 14(7):926-934. PubMed ID: 27593184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugs.
    Almeida H; Amaral MH; Lobão P; Lobo JM
    J Pharm Pharm Sci; 2012; 15(4):592-605. PubMed ID: 23106961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organogels in Drug Delivery: A Special Emphasis on Pluronic Lecithin Organogels.
    Alsaab H; Bonam SP; Bahl D; Chowdhury P; Alexander K; Boddu SH
    J Pharm Pharm Sci; 2016; 19(2):252-73. PubMed ID: 27518174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of Metronidazole Suspensions.
    Donnelly RF; Ying J
    Int J Pharm Compd; 2015; 19(3):248-51. PubMed ID: 26714365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the percutaneous absorption of promethazine hydrochloride, in vitro, using the human ex vivo skin model.
    Bassani AS; Banov D; Lehman PA
    Int J Pharm Compd; 2008; 12(3):270-3. PubMed ID: 23969717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pluronic F127-tailored lecithin organogel of acyclovir: preclinical evidence of antiviral activity using BALB/c murine model of cutaneous HSV-1 infection.
    Sharma G; Kaur B; Thakur K; Mahajan A; Amarji B; Singh MP; Katare OP
    Drug Deliv Transl Res; 2022 Jan; 12(1):213-228. PubMed ID: 33486688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The release and transdermal penetration of baclofen formulated in a poloxamer lecithin organogel.
    Arnold JJ; Asbill S
    Int J Pharm Compd; 2009; 13(6):569-71. PubMed ID: 23965331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer.
    Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK
    Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syringeable Pluronic-α-cyclodextrin supramolecular gels for sustained delivery of vancomycin.
    Simões SM; Veiga F; Torres-Labandeira JJ; Ribeiro AC; Sandez-Macho MI; Concheiro A; Alvarez-Lorenzo C
    Eur J Pharm Biopharm; 2012 Jan; 80(1):103-12. PubMed ID: 22005155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel composite fatty acid vesicles-in-Pluronic lecithin organogels for enhanced magnolol delivery in skin cancer treatment.
    Atef B; Ishak RAH; Badawy SS; Osman R
    Eur J Pharm Biopharm; 2024 Aug; 201():114379. PubMed ID: 38908488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.